TESAMORELIN 5mg

Description

Product Information

If you are looking to buy Tesamorelin peptide in the UK, VITALA’s Tesamorelin 5mg vial is one of the most precisely formulated research-grade options available from a domestic UK supplier today.

Tesamorelin is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH) — the hormone naturally produced by the hypothalamus to signal the pituitary gland to release growth hormone. What sets Tesamorelin apart from other GHRH analogues is that it is a full-length analogue, meaning it mirrors the complete 44-amino acid structure of endogenous GHRH with a modification that significantly improves its stability and resistance to enzymatic breakdown.

This stability makes Tesamorelin one of the most durable and well-characterised GHRH analogues available for research. It stimulates growth hormone release in a physiologically consistent manner — working through the body’s own regulatory feedback systems rather than bypassing them — which gives researchers a uniquely naturalistic model for studying GH dynamics and their downstream metabolic effects.

Tesamorelin supports increased growth hormone secretion, significant reduction in visceral fat, improved body composition, better metabolic health, enhanced cognitive function, and healthier cardiovascular markers. It is one of the most thoroughly researched GHRH analogues in peptide science, with a particularly strong evidence base around visceral adiposity and metabolic dysfunction.

VITALA’s Tesamorelin 5mg vial gives UK researchers a stable, high-purity lyophilised compound that delivers consistent, reliable results across a broad range of endocrinological and metabolic study protocols.

Research Focus

Tesamorelin has built one of the most robust research profiles of any synthetic GHRH analogue. Its ability to stimulate physiologically patterned GH release — combined with its well-documented effects on visceral fat and metabolic health — has made it a cornerstone compound in growth hormone, body composition, and metabolic disease research.

In UK laboratory settings, the VITALA Tesamorelin 5mg vial is currently being used to explore:

Growth Hormone Secretion: Tesamorelin stimulates the anterior pituitary to release growth hormone by binding directly to GHRH receptors. Unlike some secretagogues that bypass the body’s natural feedback loops, Tesamorelin works within them — meaning GH release remains subject to normal physiological regulation. Researchers are studying the pattern, amplitude, and downstream effects of this GH stimulation across different research models.

Visceral Fat Reduction: One of the most extensively studied effects of Tesamorelin is its ability to reduce visceral adipose tissue — the deep abdominal fat that surrounds internal organs and is closely linked to metabolic disease risk. Researchers are investigating the mechanisms behind this effect and how GH-driven lipolysis specifically targets visceral fat stores.

Body Composition and Lean Mass: Alongside visceral fat reduction, Tesamorelin has been studied for its positive effects on lean body mass. Studies are examining how GH elevation influences protein synthesis, muscle maintenance, and overall body composition in different research models.

Metabolic Health and Lipid Profiles: Tesamorelin’s influence on growth hormone has meaningful downstream effects on lipid metabolism. Researchers are investigating how it affects triglyceride levels, cholesterol profiles, insulin sensitivity, and broader markers of cardiometabolic health.

Cognitive Function and Brain Health: An increasingly active area of Tesamorelin research involves its effects on cognition. Studies have observed improvements in memory, executive function, and cognitive processing speed in research models, with researchers now investigating whether GH and IGF-1 elevation plays a direct role in supporting brain health and neurological function.

IGF-1 Regulation: Tesamorelin stimulates the liver to produce Insulin-like Growth Factor 1 (IGF-1) as part of the downstream GH axis. Researchers are studying how this IGF-1 elevation affects cellular growth, tissue repair, metabolic function, and its interaction with the broader endocrine system.

Cardiovascular Health Markers: Visceral fat accumulation is one of the most significant risk factors for cardiovascular disease. By studying Tesamorelin’s effects on visceral adiposity and lipid profiles, researchers are gaining important insights into how GH axis modulation may influence long-term cardiovascular health outcomes.

Ageing and Somatopause Research: Growth hormone levels decline naturally and significantly with age — a process known as somatopause. Tesamorelin is an important research tool for studying how restoring more youthful GH secretion patterns affects the metabolic, physical, and cognitive changes associated with ageing.

Composition of the Tesamorelin Research Vial

VITALA Tesamorelin is a single-compound research vial, giving researchers a clean and precisely dosed tool for studying this full-length GHRH analogue in a controlled laboratory setting.

Tesamorelin: 5mg — A synthetic analogue of endogenous Growth Hormone Releasing Hormone (GHRH), consisting of the complete 44-amino acid sequence of human GHRH with a trans-3-hexenoic acid modification at the N-terminus that significantly improves its stability and resistance to dipeptidyl peptidase IV (DPP-IV) degradation. Tesamorelin binds to pituitary GHRH receptors and stimulates growth hormone release within the body’s natural physiological feedback framework. It supports increased GH secretion, significant visceral fat reduction, improved body composition, better metabolic and cardiovascular health markers, enhanced cognitive function, and elevated IGF-1 levels.

The compound is supplied as a lyophilised (freeze-dried) powder. It requires reconstitution with bacteriostatic water under sterile laboratory conditions before use. This format ensures maximum peptide stability during transit and provides an extended shelf life when stored at the correct temperature.

Why Choose VITALA Tesamorelin from Peptide Shop UK

Tesamorelin is a compound with a high bar for research accuracy — and that starts with the quality of the peptide itself. Every VITALA Tesamorelin 5mg vial is independently tested and confirmed to a purity of greater than 98% using High-Performance Liquid Chromatography (HPLC). Every vial, every batch, every order meets the same verified standard.

Each vial is sealed under sterile manufacturing conditions, so the peptide arrives at your laboratory fully protected from contamination and ready for use. Whether you are studying GH dynamics, visceral fat metabolism, or the cognitive effects of IGF-1 elevation, the consistency and integrity of your compound is never in question.

For UK researchers who need to buy Tesamorelin peptide from a reliable domestic source, Peptide Shop UK offers fast tracked delivery, transparent purity documentation, and a research-grade product range built specifically for the scientific community. Quality you can depend on, from the first vial to the last.

Product Specifications

Product Name: Tesamorelin Format: Lyophilised Powder – Injectable Vial Total Peptide Content: 5mg Purity: >98% (HPLC Verified) Reconstitution: Bacteriostatic Water Required Intended Use: Research & Development Only

Storage and Laboratory Handling

Storing your Tesamorelin vial is simple and important. Before reconstitution, keep the vial refrigerated at between 2°C and 8°C and away from direct sunlight. Do not freeze the lyophilised powder as this can damage the structural integrity of the peptide.

Once reconstituted with bacteriostatic water, store the solution in the refrigerator and use it within the recommended stability window for bacteriostatic peptide preparations. Always replace the cap securely after each laboratory use to maintain a sterile environment and protect the remaining compound from degradation.

Regulatory Status in the UK

Tesamorelin is sold strictly for Research and Development (R&D) use within the United Kingdom. It is not a licensed medicinal product and is not approved for human consumption or clinical administration. All research involving this compound must be conducted within a registered laboratory setting and in full compliance with applicable UK regulations.

Who Is This Product For

VITALA Tesamorelin 5mg is intended for UK-based endocrinologists, metabolic researchers, physiologists, biochemists, and qualified laboratory professionals actively working in the fields of growth hormone research, visceral fat and obesity science, cardiometabolic health, cognitive neuroscience, and peptide pharmacology. It is not suitable for personal use or self-administration.

Shipping and Delivery

All VITALA orders placed through Peptide Shop UK are dispatched domestically via Royal Mail Tracked Delivery. Your vials are carefully packaged to protect lyophilised compounds throughout the delivery journey. Most UK orders arrive within 2 to 4 working days from the date of dispatch — keeping your research on schedule without unnecessary delays.

All peptides sold by Peptide Shop UK under the VITALA brand are intended for Research and Development (R&D) purposes only.